Literature DB >> 20588164

HLA-B alleles associate consistently with HIV heterosexual transmission, viral load, and progression to AIDS, but not susceptibility to infection.

Xiaojiang Gao1, Thomas R O'Brien, Tania M Welzel, Darlene Marti, Ying Qi, James J Goedert, John Phair, Ruth Pfeiffer, Mary Carrington.   

Abstract

OBJECTIVE: HLA class I polymorphism is known to affect the rate of progression to AIDS after infection with HIV-1. Here we test the consistency of HLA-B allelic effects on progression to AIDS, heterosexual HIV transmission, and 'set point' viral levels.
METHODS: We used adjusted Cox proportional hazard models in previously published relative hazard values for the effect of HLA-B alleles on progression to AIDS (n = 1089). The transmission study included 303 HIV-1-infected men with hemophilia and their 323 female sex partners (Multicenter Hemophilia Cohort Study cohort). Among 259 HIV-1 seroconverters (Multicenter AIDS Cohort Study cohort), HIV RNA levels at 'set point' were determined in stored plasma samples by a reverse-transcription polymerase chain reaction assay. HLA-B genotyping was performed by sequence-specific oligonucleotide hybridization and DNA sequencing.
RESULTS: Several HLA-B alleles showed consistent associations for AIDS risk, infectivity, and 'set point' HIV RNA. HLA-B*35 was associated with more rapid progression to AIDS (relative hazard 1.39; P = 0.008), greater infectivity (odds ratio 3.14; P = 0.002), and higher HIV RNA (P = 0.01), whereas the presence of either B*27 or B*57 associated with slower progression to AIDS (B*27: relative hazard 0.49, P < 0.001; B*57: relative hazard 0.40, P < 0.0001), less infectivity (odds ratio 0.22 and 0.31, respectively, though not significant), and lower viral levels (P < 0.0001). Importantly, HLA-B polymorphism in female partners was not associated with susceptibility to HIV-1 infection.
CONCLUSION: HLA-B polymorphisms that affect the risk of AIDS may also alter HIV-1 infectivity, probably through the common mechanism of viral control, but they do not appear to protect against infection in our cohort.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20588164      PMCID: PMC2902625          DOI: 10.1097/QAD.0b013e32833c3219

Source DB:  PubMed          Journal:  AIDS        ISSN: 0269-9370            Impact factor:   4.177


  23 in total

1.  Influence of HLA-B57 on clinical presentation and viral control during acute HIV-1 infection.

Authors:  Marcus Altfeld; Marylyn M Addo; Eric S Rosenberg; Frederick M Hecht; Paul K Lee; Martin Vogel; Xu G Yu; Rika Draenert; Mary N Johnston; Daryld Strick; Todd M Allen; Margaret E Feeney; James O Kahn; Rafick P Sekaly; Jay A Levy; Jürgen K Rockstroh; Philip J Goulder; Bruce D Walker
Journal:  AIDS       Date:  2003-12-05       Impact factor: 4.177

2.  AIDS restriction HLA allotypes target distinct intervals of HIV-1 pathogenesis.

Authors:  Xiaojiang Gao; Arman Bashirova; Astrid K N Iversen; John Phair; James J Goedert; Susan Buchbinder; Keith Hoots; David Vlahov; Marcus Altfeld; Stephen J O'Brien; Mary Carrington
Journal:  Nat Med       Date:  2005-11-20       Impact factor: 53.440

3.  HLA-B Bw4 alleles and HIV-1 transmission in heterosexual couples.

Authors:  Tania M Welzel; Xiaojiang Gao; Ruth M Pfeiffer; Maureen P Martin; Stephen J O'Brien; James J Goedert; Mary Carrington; Thomas R O'Brien
Journal:  AIDS       Date:  2007-01-11       Impact factor: 4.177

4.  Cross-reactive cytotoxic T lymphocytes against a HIV-1 p24 epitope in slow progressors with B*57.

Authors:  Geraldine M A Gillespie; Rupert Kaul; Tao Dong; Hong-Bing Yang; Tim Rostron; Job J Bwayo; Peter Kiama; Tim Peto; Francis A Plummer; Andrew J McMichael; Sarah L Rowland-Jones
Journal:  AIDS       Date:  2002-05-03       Impact factor: 4.177

5.  Predictive value of plasma HIV RNA level on rate of CD4 T-cell decline in untreated HIV infection.

Authors:  Benigno Rodríguez; Ajay K Sethi; Vinay K Cheruvu; Wilma Mackay; Ronald J Bosch; Mari Kitahata; Stephen L Boswell; W Christopher Mathews; David R Bangsberg; Jeffrey Martin; Christopher C Whalen; Scott Sieg; Suhrida Yadavalli; Steven G Deeks; Michael M Lederman
Journal:  JAMA       Date:  2006-09-27       Impact factor: 56.272

6.  Maternal HLA homozygosity and mother-child HLA concordance increase the risk of vertical transmission of HIV-1.

Authors:  Romel D Mackelprang; Grace John-Stewart; Mary Carrington; Barbra Richardson; Sarah Rowland-Jones; Xiaojiang Gao; Dorothy Mbori-Ngacha; Jennifer Mabuka; Barbara Lohman-Payne; Carey Farquhar
Journal:  J Infect Dis       Date:  2008-04-15       Impact factor: 5.226

Review 7.  The influence of HLA genotype on AIDS.

Authors:  Mary Carrington; Stephen J O'Brien
Journal:  Annu Rev Med       Date:  2001-12-03       Impact factor: 13.739

8.  Mother-to-child transmission of HIV-1: strong association with certain maternal HLA-B alleles independent of viral load implicates innate immune mechanisms.

Authors:  Robert Winchester; Jane Pitt; Manhattan Charurat; Laurence S Magder; Harald H H Göring; Alan Landay; Jennifer S Read; William Shearer; Edward Handelsman; Katherine Luzuriaga; George V Hillyer; William Blattner
Journal:  J Acquir Immune Defic Syndr       Date:  2004-06-01       Impact factor: 3.731

9.  A whole-genome association study of major determinants for host control of HIV-1.

Authors:  Jacques Fellay; Kevin V Shianna; Dongliang Ge; Sara Colombo; Bruno Ledergerber; Mike Weale; Kunlin Zhang; Curtis Gumbs; Antonella Castagna; Andrea Cossarizza; Alessandro Cozzi-Lepri; Andrea De Luca; Philippa Easterbrook; Patrick Francioli; Simon Mallal; Javier Martinez-Picado; José M Miro; Niels Obel; Jason P Smith; Josiane Wyniger; Patrick Descombes; Stylianos E Antonarakis; Norman L Letvin; Andrew J McMichael; Barton F Haynes; Amalio Telenti; David B Goldstein
Journal:  Science       Date:  2007-07-19       Impact factor: 47.728

10.  Roles for HLA and KIR polymorphisms in natural killer cell repertoire selection and modulation of effector function.

Authors:  Makoto Yawata; Nobuyo Yawata; Monia Draghi; Ann-Margaret Little; Fotini Partheniou; Peter Parham
Journal:  J Exp Med       Date:  2006-03-13       Impact factor: 14.307

View more
  28 in total

1.  HLA alleles are associated with altered risk for disease progression and central nervous system impairment of HIV-infected children.

Authors:  Kumud K Singh; Ping Kathryn Gray; Yan Wang; Terence Fenton; Rodney N Trout; Stephen A Spector
Journal:  J Acquir Immune Defic Syndr       Date:  2011-05-01       Impact factor: 3.731

2.  Low-level Viremia early in HIV infection.

Authors:  Iris Chen; Vanessa Cummings; Jessica M Fogel; Mark A Marzinke; William Clarke; Matthew B Connor; Sam Griffith; Susan Buchbinder; Steven Shoptaw; Carlos Del Rio; Manya Magnus; Sharon Mannheimer; Darrell P Wheeler; Kenneth H Mayer; Beryl A Koblin; Susan H Eshleman
Journal:  J Acquir Immune Defic Syndr       Date:  2014-12-01       Impact factor: 3.731

3.  Virological and immunological factors associated with HIV-1 differential disease progression in HLA-B 58:01-positive individuals.

Authors:  D R Chopera; M Mlotshwa; Z Woodman; K Mlisana; D de Assis Rosa; D P Martin; S Abdool Karim; C M Gray; C Williamson
Journal:  J Virol       Date:  2011-05-25       Impact factor: 5.103

4.  Transmission and evolution of hepatitis C virus in HCV seroconverters in HIV infected subjects.

Authors:  Chengli Shen; Phalguni Gupta; Xiaochuan Xu; Anwesha Sanyal; Charles Rinaldo; Eric Seaberg; Joseph B Margolick; Otoniel Martinez-Maza; Yue Chen
Journal:  Virology       Date:  2013-12-22       Impact factor: 3.616

5.  Dynamics of viremia in primary HIV-1 infection in Africans: insights from analyses of host and viral correlates.

Authors:  Heather A Prentice; Matthew A Price; Travis R Porter; Emmanuel Cormier; Michael J Mugavero; Anatoli Kamali; Etienne Karita; Shabir Lakhi; Eduard J Sanders; Omu Anzala; Pauli N Amornkul; Susan Allen; Eric Hunter; Richard A Kaslow; Jill Gilmour; Jianming Tang
Journal:  Virology       Date:  2013-12-12       Impact factor: 3.616

6.  Transmitted raltegravir resistance in an HIV-1 CRF_AG-infected patient.

Authors:  Sarita D Boyd; Frank Maldarelli; Irini Sereti; G Laissa Ouedraogo; Catherine A Rehm; Valerie Boltz; Diana Shoemaker; Alice K Pau
Journal:  Antivir Ther       Date:  2011

7.  Human leukocyte antigen variants B*44 and B*57 are consistently favorable during two distinct phases of primary HIV-1 infection in sub-Saharan Africans with several viral subtypes.

Authors:  Jianming Tang; Emmanuel Cormier; Jill Gilmour; Matthew A Price; Heather A Prentice; Wei Song; Anatoli Kamali; Etienne Karita; Shabir Lakhi; Eduard J Sanders; Omu Anzala; Pauli N Amornkul; Susan Allen; Eric Hunter; Richard A Kaslow
Journal:  J Virol       Date:  2011-06-29       Impact factor: 5.103

8.  HLA class I and KIR genes do not protect against HIV type 1 infection in highly exposed uninfected individuals with hemophilia A.

Authors:  Nicolas Vince; Arman A Bashirova; Alexandra Lied; Xiaojiang Gao; Lucy Dorrell; Paul J McLaren; Jacques Fellay; Mary Carrington
Journal:  J Infect Dis       Date:  2014-04-08       Impact factor: 5.226

9.  HLA Class I Alleles Associated with Mortality in Thai Military Recruits with HIV-1 CRF01_AE Infection.

Authors:  Rajesh T Gandhi; Ronald J Bosch; Ram Rangsin; Thippawan Chuenchitra; Narongrid Sirisopana; Jerome H Kim; Merlin L Robb; Sasijit Vejbaesya; Robert M Paris; Kenrad E Nelson
Journal:  AIDS Res Hum Retroviruses       Date:  2015-09-18       Impact factor: 2.205

10.  A sequence-based approach demonstrates that balancing selection in classical human leukocyte antigen (HLA) loci is asymmetric.

Authors:  Paola G Bronson; Steven J Mack; Henry A Erlich; Montgomery Slatkin
Journal:  Hum Mol Genet       Date:  2012-10-12       Impact factor: 6.150

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.